NYSE:ALB - Albemarle Stock Price, Price Target & More

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, June 15th will be given a dividend of $0.335 per share on Monday, July 2nd. This represents a $1.34 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date is Thursday, June 14th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Wednesday, May, 9th. The specialty chemicals company reported $1.30 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.20 by $0.10. The specialty chemicals company had revenue of $821.60 million for the quarter, compared to analysts' expectations of $798.20 million. Albemarle had a return on equity of 13.80% and a net margin of 4.27%. The company's quarterly revenue was up 13.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.05 earnings per share. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Albemarle.

Albemarle updated its FY18 earnings guidance on Wednesday, May, 9th. The company provided earnings per share guidance of $5.10-5.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.17. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.30 billion.

22 brokers have issued 1-year price objectives for Albemarle's shares. Their predictions range from $106.00 to $157.00. On average, they anticipate Albemarle's stock price to reach $132.0255 in the next twelve months. This suggests a possible upside of 41.0% from the stock's current price. View Analyst Ratings for Albemarle.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical Co. ADR Class H (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), Cereplast (CERPQ) and ForceField Energy (FNRG).

Media headlines about ALB stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a daily sentiment score of 0.17 on Accern's scale. They also assigned media coverage about the specialty chemicals company an impact score of 45.92 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (2.36%), KAMES CAPITAL plc (0.47%), Handelsbanken Fonder AB (0.23%), Hardman Johnston Global Advisors LLC (0.18%), Scout Investments Inc. (0.12%) and Nikko Asset Management Americas Inc. (0.09%). Company insiders that own Albemarle stock include Douglas L Maine, John Sherman Jr, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., Hardman Johnston Global Advisors LLC, Essex Investment Management Co. LLC, Hartford Investment Management Co., Municipal Employees Retirement System of Michigan, Fjarde AP Fonden Fourth Swedish National Pension Fund, State of Alaska Department of Revenue and Retirement Systems of Alabama. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Matthew Juneau. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Handelsbanken Fonder AB, Scout Investments Inc., Nikko Asset Management Americas Inc., KAMES CAPITAL plc, Capital Asset Advisory Services LLC, IFM Investors Pty Ltd and DnB Asset Management AS. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $93.64.

Albemarle has a market capitalization of $10.72 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.